According to market intelligence from Intel Market Research, the global Hepatinica market was valued at USD 1.85 billion in 2025 and is projected to reach USD 3.47 billion by 2034, growing at a steady CAGR of 7.1% during the forecast period (2026-2034). This expansion reflects the mounting global healthcare burden of liver disorders and accelerating adoption of hepatoprotective therapies.
📥...
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek